Incidence of Cefixime Resistance in Patients with Chronic Kidney Disease at Harapan Keluarga Hospital
DOI:
10.29303/jbt.v25i2.8801Published:
2025-04-10Downloads
Abstract
Antibiotic resistance is an increasing global health challenge, especially in patients with advanced chronic kidney disease (CKD). This study aims to investigate cefixime resistance in patients with stage 4-5 CKD at Harapan Keluarga Hospital with a retrospective cohort design using medical record data. Chi-squared test analysis showed a significant association between cefixime resistance and advanced CKD (χ² = 34.714, p = 0.003). The results showed a higher prevalence of cefixime resistance in male patients (60%), antibiotic use of more than 14 days (65%), and hospitalization of more than five days (80%). The mechanism of resistance involves beta-lactamase production and changes in the gut microbiota due to dysbiosis. Factors such as irrational antibiotic use, length of hospital stay, and catheter use contributed to higher resistance. This study highlights the need for evidence-based antibiotic stewardship strategies to reduce resistance, especially in vulnerable populations such as patients with advanced CKD. Scientific implications include the development of more effective infection management strategies, close monitoring of antibiotic use, dose adjustment according to CKD severity, and education of health care workers to increase awareness of antibiotic resistance. This study contributes to efforts to prevent antibiotic resistance in the advanced CKD population.
Keywords:
antibiotics; cefixime resistance; chronic kidney disease (CKD); comorbidities.References
Ahmed, N., Khalid, H., Mushtaq, M., Basha, S., Rabaan, A. A., Garout, M., Halwani, M. A., Al Mutair, A., Alhumaid, S., Al Alawi, Z., & Yean, C. Y. (2022). The Molecular Characterization of Virulence Determinants and Antibiotic Resistance Patterns in Human Bacterial Uropathogens. Antibiotics, 11(4). https://doi.org/10.3390/antibiotics11040516
Al-Tamimi, M., Albalawi, H., Shalabi, M., Abu-Raideh, J., Khasawneh, A. I., & Alhaj, F. (2022). Cefixime and cefixime-clavulanate for screening and confirmation of extended-spectrum beta-lactamases in Escherichia coli. Annals of Clinical Microbiology and Antimicrobials, 21(1). https://doi.org/10.1186/s12941-022-00508-4
Ammirati, A. L. (2020). Chronic kidney disease. In Revista da Associacao Medica Brasileira (Vol. 66, pp. 3–9). Associacao Medica Brasileira. https://doi.org/10.1590/1806-9282.66.S1.3
Chahine, B. (2022). Antibiotic dosing adjustments in hospitalized patients with chronic kidney disease: a retrospective chart review. International Urology and Nephrology, 54(1), 157–163. https://doi.org/10.1007/s11255-021-02834-6
Chen, T. K., Knicely, D. H., & Grams, M. E. (2019). Chronic Kidney Disease Diagnosis and Management: A Review. In JAMA - Journal of the American Medical Association (Vol. 322, Issue 13, pp. 1294–1304). American Medical Association. https://doi.org/10.1001/jama.2019.14745
Chhakchhuak, M., Chaturvedy, M., Agarwal, J., Tak, V., & Bajpai, N. K. (2023). Retrospective Analysis of Spectrum of Infections and Antibiotic Resistance Pattern in Chronic Kidney Disease Patients on Maintenance Hemodialysis in a Tertiary Care Centre in North India. Indian Journal of Nephrology, 33(3), 177–182. https://doi.org/10.4103/ijn.ijn_238_21
Dicu-Andreescu, I., Penescu, M. N., Căpușă, C., & Verzan, C. (2023). Chronic Kidney Disease, Urinary Tract Infections and Antibiotic Nephrotoxicity: Are There Any Relationships? In Medicina (Lithuania) (Vol. 59, Issue 1). MDPI. https://doi.org/10.3390/medicina59010049
Feneley, R. C. L., Hopley, I. B., & Wells, P. N. T. (2015). Urinary catheters: History, current status, adverse events and research agenda. Journal of Medical Engineering and Technology, 39(8), 459–470. https://doi.org/10.3109/03091902.2015.1085600
Haque Sumon, A. H. M. S., Al-Mahmood, Md. R., Islam, K. A., Karim, A. N. M. E., Aker, P., Ullah, A., Rashid, M. A., & Hasan, M. N. (2023). Multidrug Resistance Urinary Tract Infection in Chronic Kidney Disease Patients: An Observational Study. Cureus. https://doi.org/10.7759/cureus.38571
Hidayangsih, P. S., Tjandrarini, D. H., Widya Sukoco, N. E., Sitorus, N., Dharmayanti, I., & Ahmadi, F. (2023). Chronic kidney disease in Indonesia: evidence from a national health survey. Osong Public Health and Research Perspectives, 14(1), 23–30. https://doi.org/10.24171/j.phrp.2022.0290
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020). Antibiotic resistance and persistence—Implications for human health and treatment perspectives. EMBO Reports, 21(12). https://doi.org/10.15252/embr.202051034
Kovesdy, C. P. (2022). Epidemiology of chronic kidney disease: an update 2022. In Kidney International Supplements (Vol. 12, Issue 1, pp. 7–11). Elsevier B.V. https://doi.org/10.1016/j.kisu.2021.11.003
Kusumawardani, L. A., Risni, H. W., Naurahhanan, D., & Syed Sulaiman, S. A. (2025). Assessment of Potentially Nephrotoxic Drug Prescriptions in Chronic Kidney Disease Outpatients at a Hospital in Indonesia. International Journal of Nephrology and Renovascular Disease, 18, 59–69. https://doi.org/10.2147/IJNRD.S503573
Liabeuf, S., Hafez, G., Pešić, V., Spasovski, G., Bobot, M., Mačiulaitis, R., Bumblyte, I. A., Ferreira, A. C., Farinha, A., Malyszko, J., Pépin, M., Massy, Z. A., Unwin, R., Capasso, G., & Mani, L. Y. (2024). Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease. In Clinical Kidney Journal (Vol. 17, Issue 8). Oxford University Press. https://doi.org/10.1093/ckj/sfae174
Mills, K. T., Xu, Y., Zhang, W., Bundy, J. D., Chen, C. S., Kelly, T. N., Chen, J., & He, J. (2015). A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney International, 88(5), 950–957. https://doi.org/10.1038/ki.2015.230
Munita, J. M., & Arias, C. A. (2016). Mechanisms of Antibiotic Resistance. Microbiology Spectrum, 4(2). https://doi.org/10.1128/microbiolspec.VMBF-0016-2015
Ramdhani, D., Kusuma, S. A. F., Sediana, D., Bima, A. P. H., & Khumairoh, I. (2021). Comparative study of cefixime and tetracycline as an evaluation policy driven by the antibiotic resistance crisis in Indonesia. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-98129-y
Santra, S., Agrawal, D., Kumar, S., & Mishra, S. (2015). A Study on the Drug Utilization Pattern in Patients with Chronic Kidney Disease with Emphasis on Antibiotics. Journal of Integrative Nephrology and Andrology, 2(3), 85. https://doi.org/10.4103/2225-1243.161435
Shankar, M., Narasimhappa, S., & N.S., M. (2021). Urinary Tract Infection in Chronic Kidney Disease Population: A Clinical Observational Study. Cureus. https://doi.org/10.7759/cureus.12486
Su, G., Xu, H., Riggi, E., He, Z., Lu, L., Lindholm, B., Marrone, G., Wen, Z., Liu, X., Johnson, D. W., Carrero, J. J., & Lundborg, C. S. (2018). Association of Kidney Function with Infections by Multidrug-Resistant Organisms: An Electronic Medical Record Analysis. Scientific Reports, 8(1). https://doi.org/10.1038/s41598-018-31612-1
Thomas, R., Kanso, A., & Sedor, J. R. (n.d.). Chronic Kidney Disease and Its Complications. http://www.nkdep.nih.gov/professionals/gfr_calculators/index.htm;
Vacaroiu, I. A., Cuiban, E., Geavlete, B. F., Gheorghita, V., David, C., Ene, C. V., Bulai, C., Lupusoru, G. E., Lupusoru, M., Balcangiu-Stroescu, A. E., Feier, L. F., Simion, I. S., & Radulescu, D. (2022). Chronic Kidney Disease—An Underestimated Risk Factor for Antimicrobial Resistance in Patients with Urinary Tract Infections. Biomedicines, 10(10). https://doi.org/10.3390/biomedicines10102368
Valladales-Restrepo, L. F., Henao-Salazar, J. A., Mejía-Mejía, I., Castro-Aragón, D. A., Rodríguez-Correa, N., Oyuela-Gutiérrez, M. C., Calvo-Salazar, J., Osorio-Bustamante, D., Sabogal-Ortiz, A., & Machado-Alba, J. E. (2024). Use of antibiotics in patients with chronic kidney disease: evidence from the real world. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2024.2443780
Versino, E., & Piccoli, G. B. (2019). Chronic kidney disease: The complex history of the organization of long-term care and bioethics. why now, more than ever, action is needed. In International Journal of Environmental Research and Public Health (Vol. 16, Issue 5). MDPI AG. https://doi.org/10.3390/ijerph16050785
Wang, T. Z., Kodiyanplakkal, R. P. L., & Calfee, D. P. (2019). Antimicrobial resistance in nephrology. In Nature Reviews Nephrology (Vol. 15, Issue 8, pp. 463–481). Nature Publishing Group. https://doi.org/10.1038/s41581-019-0150-7
Wehedy, E., Shatat, I. F., & Al Khodor, S. (2022). The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword. In Frontiers in Medicine (Vol. 8). Frontiers Media S.A. https://doi.org/10.3389/fmed.2021.790783
Zhen, X., Lundborg, C. S., Sun, X., Hu, X., & Dong, H. (2020). Clinical and economic impact of third-generation cephalosporin-resistant infection or colonization caused by Escherichia coli and Klebsiella pneumoniae: A multicenter study in China. International Journal of Environmental Research and Public Health, 17(24), 1–12. https://doi.org/10.3390/ijerph17249285
License
Copyright (c) 2025 Yulia Dian Theresia, Maz Isa Ansyori, Akhada Maulana, Anak Agung Ayu Niti Wedayani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
